Search by Drug Name or NDC

    NDC 23155-0763-01 Lithium carbonate 300 mg/1 Details

    Lithium carbonate 300 mg/1

    Lithium carbonate is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is LITHIUM CARBONATE.

    Product Information

    NDC 23155-0763
    Product ID 23155-763_9050ff15-5fa6-4c8b-b312-aedf4fd6175b
    Associated GPIs 59500010100405
    GCN Sequence Number 004004
    GCN Sequence Number Description lithium carbonate TABLET ER 300 MG ORAL
    HIC3 H2M
    HIC3 Description BIPOLAR DISORDER DRUGS
    GCN 15731
    HICL Sequence Number 001669
    HICL Sequence Number Description LITHIUM CARBONATE
    Brand/Generic Generic
    Proprietary Name Lithium carbonate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lithium carbonate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name LITHIUM CARBONATE
    Labeler Name Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Pharmaceutical Class Mood Stabilizer [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205532
    Listing Certified Through 2024-12-31

    Package

    NDC 23155-0763-01 (23155076301)

    NDC Package Code 23155-763-01
    Billing NDC 23155076301
    Package 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (23155-763-01)
    Marketing Start Date 2020-10-20
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.15422
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description LITHIUM CARBONATE ER 300 MG TB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis